The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Northcott John since 2015.
This trader's CIK number is 1615000.
At the time of last reporting, Northcott John was the SVP & Chief Commercial Officer of Nektar Therapeutics. (stock ticker symbol NKTR).
Also see all insider trading activities at Nektar Therapeutics.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2015 | LXRX | 0 | $0 | 0 | $0 | 11,250 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | NKTR | 0 | $0 | 9,444 | $71,267 | 0 | $0 |
| 2021 | NKTR | 0 | $0 | 33,696 | $620,310 | 0 | $0 |
1. Lexicon Pharmaceuticals, Inc. (LXRX)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2015-03-02 | LXRX | Option Ex | 11,250 | .00 | 0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-05-16 | NKTR | Sale | 4,592 | 3.95 | 18,138 |
| 2022-02-16 | NKTR | Sale | 4,852 | 10.95 | 53,129 |
| 2021-11-16 | NKTR | Sale | 6,061 | 13.16 | 79,762 |
| 2021-08-16 | NKTR | Sale | 6,192 | 13.83 | 85,635 |
| 2021-05-17 | NKTR | Sale | 6,085 | 18.30 | 111,355 |
| 2021-02-16 | NKTR | Sale | 15,358 | 22.37 | 343,558 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Northcott John (SVP & Chief Commercial Officer of Nektar Therapeutics at the time of this reporting) see the Securities and Exchange Commission (SEC) website.